Skip to content
Search

Latest Stories

Submit Guest Post

Teaser of Yash, Sanjay Dutt and Raveena Tandon starrer K.G.F: Chapter 2 is powerful and engaging

Teaser of Yash, Sanjay Dutt and Raveena Tandon starrer K.G.F: Chapter 2 is powerful and engaging

By Murtuza Iqbal

In 2018, a Kannada film titled K.G.F: Chapter 1 starring Yash had hit the big screens. The movie was a blockbuster at the box office and became the highest-grossing Kannada film. Even the Hindi dubbed version had done a good business.


Everyone has been waiting for K.G.F: Chapter 2, and to make it grand and a pan-India film, the makers roped in two Bollywood stars, Sanjay Dutt and Raveena Tandon.

Today, on Yash’s birthday, the makers have released the teaser of the film. Director Prashanth Neel took to Twitter to share the teaser with everyone.

He tweeted, “A promise was once made, that promise will be kept! https://youtu.be/Qah9sSIXJqk Wishing Rocking Star @TheNameIsYash a very Happy Birthday. #KGF2Teaser #HBDRockyBhai @VKiragandur @prashanth_neel @hombalefilms @duttsanjay @TandonRaveena @SrinidhiShetty7 @BasrurRavi @bhuvangowda84.”

The teaser of the film is damn good and keeps us engaged for those 2 minutes 16 seconds. Yash is looking dapper in the teaser and Raveena Tandon leaves a mark with her strong presence. We also get to see a small glimpse of Sanjay Dutt in it and Srinidhi Shetty is looking pretty in the teaser.

Well, after watching the teaser of K.G.F: Chapter 2, we are sure moviegoers would be excited to watch the film. The makers have not yet announced the release date of the film, but they have confirmed that it will release in cinemas. Last year, there were reports that the film might get a direct-to-digital release; however, Yash had denied the reports.

Add EasternEye As Your Trusted Source
preferred source on google news

More For You

Hair Loss risks

Popular GLP-1 weight loss drugs are facing fresh scrutiny over reports of hair loss.

iStock

Hair loss risk up by 68 per cent? New study puts GLP-1 drugs under the spotlight

  • Researchers found GLP-1 drugs were associated with up to a 68 per cent higher risk of hair loss than some other diabetes medicines.
  • UK regulators have received more than 1,200 reports of hair loss linked to semaglutide and tirzepatide since last year.
  • Experts say rapid weight loss may be the most likely explanation, but further research is needed.

Popular GLP-1 weight loss drugs such as Mounjaro, Ozempic and Wegovy are under fresh scrutiny after a major study found they may be linked to a higher risk of hair loss. The findings add to a growing number of reports already being reviewed by health regulators in both the UK and the US, although researchers say more evidence is needed before any direct link can be confirmed.

The study, published in the British Medical Journal (BMJ), analysed health records from around 50,000 adults and compared people taking GLP-1 receptor agonists with those using other medicines to manage type 2 diabetes. Researchers found that people using GLP-1 drugs had a 37 per cent higher risk of developing alopecia than those taking SGLT-2 inhibitors, while the risk was 68 per cent higher compared with people using DPP-4 inhibitors.

Keep ReadingShow less